125 related articles for article (PubMed ID: 11835189)
1. Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Giralt M; Camats J; Hidalgo J
J Comp Neurol; 2002 Mar; 444(2):174-89. PubMed ID: 11835189
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Camats J; Hadberg H; Quintana A; Rojas S; Giralt M; Molinero A; Campbell IL; Hidalgo J
J Neurosci Res; 2003 Aug; 73(4):481-96. PubMed ID: 12898533
[TBL] [Abstract][Full Text] [Related]
4. M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.
Penkowa M; Poulsen C; Carrasco J; Hidalgo J
Exp Neurol; 2002 Aug; 176(2):308-21. PubMed ID: 12359172
[TBL] [Abstract][Full Text] [Related]
5. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment.
Penkowa M; Hidalgo J
Exp Neurol; 2000 May; 163(1):72-84. PubMed ID: 10785446
[TBL] [Abstract][Full Text] [Related]
6. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice.
Penkowa M; Giralt M; Moos T; Thomsen PS; Hernández J; Hidalgo J
Exp Neurol; 1999 Mar; 156(1):149-64. PubMed ID: 10192786
[TBL] [Abstract][Full Text] [Related]
7. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice.
Penkowa M; Giralt M; Carrasco J; Hadberg H; Hidalgo J
Glia; 2000 Dec; 32(3):271-85. PubMed ID: 11102968
[TBL] [Abstract][Full Text] [Related]
8. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice.
Carrasco J; Penkowa M; Hadberg H; Molinero A; Hidalgo J
Eur J Neurosci; 2000 Jul; 12(7):2311-22. PubMed ID: 10947810
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein-1+2 protect the CNS after a focal brain injury.
Giralt M; Penkowa M; Lago N; Molinero A; Hidalgo J
Exp Neurol; 2002 Jan; 173(1):114-28. PubMed ID: 11771944
[TBL] [Abstract][Full Text] [Related]
10. Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice.
Wiese L; Kurtzhals JA; Penkowa M
Exp Neurol; 2006 Jul; 200(1):216-26. PubMed ID: 16624296
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures.
Penkowa M; Florit S; Giralt M; Quintana A; Molinero A; Carrasco J; Hidalgo J
J Neurosci Res; 2005 Feb; 79(4):522-34. PubMed ID: 15614785
[TBL] [Abstract][Full Text] [Related]
12. Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis.
Penkowa M; Espejo C; Martínez-Cáceres EM; Poulsen CB; Montalban X; Hidalgo J
J Neuroimmunol; 2001 Oct; 119(2):248-60. PubMed ID: 11585628
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6.
Molinero A; Penkowa M; Hernández J; Camats J; Giralt M; Lago N; Carrasco J; Campbell IL; Hidalgo J
J Neuropathol Exp Neurol; 2003 Mar; 62(3):315-28. PubMed ID: 12638735
[TBL] [Abstract][Full Text] [Related]
14. Enteric gliopathy in niacin-deficiency induced by CNS glio-toxin.
Aikawa H; Suzuki K
Brain Res; 1985 May; 334(2):354-6. PubMed ID: 3158379
[TBL] [Abstract][Full Text] [Related]
15. Zinc- or cadmium-pre-induced metallothionein protects human central nervous system cells and astrocytes from radiation-induced apoptosis.
Cai L; Iskander S; Cherian MG; Hammond RR
Toxicol Lett; 2004 Feb; 146(3):217-26. PubMed ID: 14687759
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures.
Penkowa M; Molinero A; Carrasco J; Hidalgo J
Neuroscience; 2001; 102(4):805-18. PubMed ID: 11182244
[TBL] [Abstract][Full Text] [Related]
17. Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice.
Kang YJ; Li Y; Sun X; Sun X
Am J Pathol; 2003 Oct; 163(4):1579-86. PubMed ID: 14507664
[TBL] [Abstract][Full Text] [Related]
18. CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.
Penkowa M; Carrasco J; Giralt M; Moos T; Hidalgo J
J Neurosci; 1999 Apr; 19(7):2535-45. PubMed ID: 10087067
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis.
Penkowa M; Hidalgo J
Glia; 2000 Dec; 32(3):247-63. PubMed ID: 11102966
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein I and II mitigate age-dependent secondary brain injury.
Natale JE; Knight JB; Cheng Y; Rome JE; Gallo V
J Neurosci Res; 2004 Nov; 78(3):303-14. PubMed ID: 15389833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
